{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:30:53Z","timestamp":1793374253586,"version":"4.5.0"},"reference-count":50,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council, New Zealand","doi-asserted-by":"crossref","award":["23\/126"],"award-info":[{"award-number":["23\/126"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,4,3]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Although short-term benefits follow parenteral ketamine for treatment-resistant major depressive disorder (TR-MDD), there are challenges that prevent routine use of ketamine by clinicians. These include acute dissociative effects of parenteral ketamine, high relapse rates following ketamine dosing and the uncertain role of psychotherapy. This randomised controlled trial (RCT) seeks to establish the feasibility of evaluating repeated oral doses of ketamine and behavioural activation therapy (BAT), compared with ketamine treatment alone, for TR-MDD. We also aim to compare relapse rates between treatment arms to determine the effect size of adding BAT to oral ketamine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This is a prospectively registered, two-centre, single-blind RCT. We aim to recruit 60 participants with TR-MDD aged between 18 and 65 years. Participants will be randomised to 8\u2009weeks of oral ketamine and BAT, or 8\u2009weeks of oral ketamine alone. Feasibility will be assessed by tracking attendance for ketamine and BAT, acceptability of treatment measures and retention to the study follow-up protocol. The primary efficacy outcome measure is the Montgomery-Asberg Depression Rating Scale (MADRS) measured weekly during treatment and fortnightly during 12 weeks of follow-up. Other outcome measures will assess the tolerability of ketamine and BAT, cognition and activity (using actigraphy). Participants will be categorised as non-responders, responders, remitters and relapsed during follow-up. MADRS scores will be analysed using a linear mixed model. For a definitive follow-up RCT study to be recommended, the recruitment expectations will be met and efficacy outcomes consistent with a &gt;20% reduction in relapse rates favouring the BAT and ketamine arm will be achieved.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>Ethics approval was granted by the New Zealand Central Health and Disability Ethics Committee (reference: 2023 FULL18176). Study findings will be reported to participants, stakeholder groups, conferences and peer-reviewed publications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>UTN: U1111-1294-9310, ACTRN12623000817640p.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-084844","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T12:12:43Z","timestamp":1714565563000},"page":"e084844","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9521-1745","authenticated-orcid":false,"given":"Ben","family":"Beaglehole","sequence":"first","affiliation":[{"name":"Psychological Medicine, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Porter","sequence":"additional","affiliation":[{"name":"Psychological Medicine, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-2959","authenticated-orcid":false,"given":"Katie","family":"Douglas","sequence":"additional","affiliation":[{"name":"Psychological Medicine, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron James","family":"Lacey","sequence":"additional","affiliation":[{"name":"Psychological Medicine, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroha","family":"de Bie","sequence":"additional","affiliation":[{"name":"Te Whatu Ora\u2013Health New Zealand Waitaha Canterbury, Christchurch, Canterbury, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jordan","sequence":"additional","affiliation":[{"name":"Psychological Medicine, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Mentzel","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, University of Otago, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgette","family":"Thwaites","sequence":"additional","affiliation":[{"name":"Psychological Medicine, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Manuel","sequence":"additional","affiliation":[{"name":"Psychological Medicine, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Murray","sequence":"additional","affiliation":[{"name":"Centre for Mental Health, Swinburne University of Technology, Hawthorn, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Frampton","sequence":"additional","affiliation":[{"name":"Psychological Medicine, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Glue","sequence":"additional","affiliation":[{"name":"Psychological Medicine, University of Otago, Dunedin School of Medicine, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"key":"2025101812573517000_14.5.e084844.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1614.2006.01903.x"},{"key":"2025101812573517000_14.5.e084844.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.08.002"},{"key":"2025101812573517000_14.5.e084844.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(02)00304-5"},{"key":"2025101812573517000_14.5.e084844.4","doi-asserted-by":"publisher","DOI":"10.1177\/0004867420979353"},{"key":"2025101812573517000_14.5.e084844.5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201300059"},{"key":"2025101812573517000_14.5.e084844.6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-017-4822-3","article-title":"Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation","volume":"235","author":"Curran","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"2025101812573517000_14.5.e084844.7","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaa087"},{"key":"2025101812573517000_14.5.e084844.8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20081251"},{"key":"2025101812573517000_14.5.e084844.9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/15622975.2023.2169349","article-title":"Oral ketamine for depression: an updated systematic review","volume":"24","author":"Meshkat","year":"2023","journal-title":"World J Biol Psychiatry"},{"key":"2025101812573517000_14.5.e084844.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.08.038"},{"key":"2025101812573517000_14.5.e084844.11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/13651501.2016.1254802","article-title":"Administration of ketamine for Unipolar and bipolar depression","volume":"21","author":"Kraus","year":"2017","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2025101812573517000_14.5.e084844.12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40263-022-00897-2","article-title":"Non-parenteral ketamine for depression: A practical discussion on addiction potential and recommendations for judicious prescribing","volume":"36","author":"Swainson","year":"2022","journal-title":"CNS Drugs"},{"key":"2025101812573517000_14.5.e084844.13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2215-0366(17)30102-5","article-title":"Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight","volume":"4","author":"Singh","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"2025101812573517000_14.5.e084844.14","doi-asserted-by":"publisher","DOI":"10.3109\/21681805.2014.909530"},{"key":"2025101812573517000_14.5.e084844.15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14740338.2022.2066651","article-title":"Long-term safety of ketamine and Esketamine in treatment of depression","volume":"21","author":"Nikayin","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"2025101812573517000_14.5.e084844.16","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2023.53","article-title":"Ketamine and psychotherapy for the treatment of psychiatric disorders: systematic review","volume":"9","author":"Kew","year":"2023","journal-title":"BJPsych Open"},{"key":"2025101812573517000_14.5.e084844.17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517074","article-title":"Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: A randomized clinical trial","volume":"90","author":"Wilkinson","year":"2021","journal-title":"Psychother Psychosom"},{"key":"2025101812573517000_14.5.e084844.18","doi-asserted-by":"crossref","first-page":"110575","DOI":"10.1016\/j.pnpbp.2022.110575","article-title":"Acute effects of ketamine and Esketamine on cognition in healthy subjects: A meta-analysis","volume":"118","author":"Zhornitsky","year":"2022","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2025101812573517000_14.5.e084844.19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2018.01.007","article-title":"Other drug use does not impact cognitive impairments in chronic ketamine users","volume":"186","author":"Zhang","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"2025101812573517000_14.5.e084844.20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"2025101812573517000_14.5.e084844.21","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.298"},{"key":"2025101812573517000_14.5.e084844.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.10.019"},{"key":"2025101812573517000_14.5.e084844.23","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00382","article-title":"A systematic review of cognitive predictors of treatment outcome in major depression","volume":"9","author":"Groves","year":"2018","journal-title":"Front Psychiatry"},{"key":"2025101812573517000_14.5.e084844.24","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m13921","article-title":"Effects of ketamine versus midazolam on Neurocognition at 24 hours in depressed patients with suicidal Ideation","volume":"82","author":"Keilp","year":"2021","journal-title":"J Clin Psychiatry"},{"key":"2025101812573517000_14.5.e084844.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.07.001"},{"key":"2025101812573517000_14.5.e084844.26","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/0004867417753549","article-title":"Clinical response to treatment in Inpatients with depression correlates with changes in activity levels and psychomotor speed","volume":"52","author":"Averill","year":"2018","journal-title":"Aust N Z J Psychiatry"},{"key":"2025101812573517000_14.5.e084844.27","doi-asserted-by":"publisher","DOI":"10.1192\/apt.bp.107.004051"},{"key":"2025101812573517000_14.5.e084844.28","unstructured":"NICE . London, UK: National Institue for Care Excellence; Depression in adults: treatment and management, 2022. Available: NG222"},{"key":"2025101812573517000_14.5.e084844.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31140-0"},{"key":"2025101812573517000_14.5.e084844.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2010.00596.x"},{"key":"2025101812573517000_14.5.e084844.31","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025101812573517000_14.5.e084844.32","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04309"},{"key":"2025101812573517000_14.5.e084844.33","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"2025101812573517000_14.5.e084844.34","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"2025101812573517000_14.5.e084844.35","doi-asserted-by":"publisher","DOI":"10.1177\/0145445510390929"},{"key":"2025101812573517000_14.5.e084844.36","unstructured":"McLachlan AH , Kinred S . He Puna Whakaata: Therapeutic Activities to Guide Change II. Wellington: Te Rau Ora, 2019."},{"key":"2025101812573517000_14.5.e084844.37","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07010042"},{"key":"2025101812573517000_14.5.e084844.38","unstructured":"Rey A . L\u2019Examen Clinique En Psychologie (the Clinical Psychological Examination).:aris1964."},{"key":"2025101812573517000_14.5.e084844.39","doi-asserted-by":"publisher","DOI":"10.1037\/1040-3590.8.2.145"},{"key":"2025101812573517000_14.5.e084844.40","doi-asserted-by":"crossref","unstructured":"Wechsler D . Wechsler Adult Intelligence Scale-III. San Antonio, Texas: The Psychological Corporation, 1997.","DOI":"10.1037\/t49755-000"},{"key":"2025101812573517000_14.5.e084844.41","doi-asserted-by":"crossref","unstructured":"Delis D , Kramer JH . Delis-Kaplan Executive Function System (D-KEFS). San Antonio, Texas: The Psychological Corporation, 2001.","DOI":"10.1037\/t15082-000"},{"key":"2025101812573517000_14.5.e084844.42","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300004"},{"key":"2025101812573517000_14.5.e084844.43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamapsychiatry.2018.3546","article-title":"Real-time mobile monitoring of the dynamic associations among motor activity, energy, mood, and sleep in adults with bipolar disorder","volume":"76","author":"Merikangas","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"2025101812573517000_14.5.e084844.44","doi-asserted-by":"publisher","DOI":"10.1348\/014466505X29657"},{"key":"2025101812573517000_14.5.e084844.45","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.180.5.461"},{"key":"2025101812573517000_14.5.e084844.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.10.004"},{"key":"2025101812573517000_14.5.e084844.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.beth.2011.04.004"},{"key":"2025101812573517000_14.5.e084844.48","unstructured":"Dimidjian H , Martell H . Quality of behavioral activation scale - short form in preparation."},{"key":"2025101812573517000_14.5.e084844.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114523"},{"key":"2025101812573517000_14.5.e084844.50","doi-asserted-by":"crossref","unstructured":"Braun C , Clarke V . Thematic Analysis: A Practical. Guide: Sage, 2021.","DOI":"10.1007\/978-3-319-69909-7_3470-2"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-084844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:57:45Z","timestamp":1760817465000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-084844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,1]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/bmjopen-2024-084844"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-084844","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}